Dishman Carbogen Amcis planning to raise funds via NCDS

25 May 2024 Evaluate

Dishman Carbogen Amcis is planning to raise funds by way of issuance of Non-Convertible Debentures (NCDs), by way of private placement, subject to such regulatory or statutory approvals as may be required. The meeting of the Board of Directors of the company will be held on May 30, 2024, inter alia, to consider, the same. 

Dishman Carbogen Amcis (DCAL), incorporated in 1983, started out as a manufacturer of quaternary ammonium and phosphate compounds. Currently, the company is a fully integrated CRAMS player working with global pharmaceutical innovators.


Dishman Carbogen Amc Share Price

175.25 1.85 (1.07%)
14-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1515.00
Dr. Reddys Lab 6080.25
Cipla 1565.50
Zydus Lifesciences 1110.95
Lupin 1601.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.